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Abstract
Objective: The objective of the study was to examine the effect of endometrioma excision on pregnancy
outcomes in women with advanced-stage endometriosis who underwent in vitro fertilization and embryo transfer
(IVF-ET). Design: This is a historical cohort study. Materials and Methods: We compared the pregnancy
outcomes of 141 women undergoing IVF-ET. The study group consisted of 25 patients who had stage III/IV
endometriosis and endometrioma excision (group 1). The control groups included 40 patients who had stage III/
IV endometriosis, but no endometrioma and who underwent ovariolysis (group 2) and 76 patients with tubal
factors infertility who underwent tubal surgery (group 3). After surgery up to two IVF-ET cycles in each group
were analyzed. Results: Our study showed that the mean total dose of gonadotropin administered in IVF-ET
cycle I was higher in group 1 compared with groups 2 and 3 ( p= 0.03). Otherwise, there was no significant
difference in the ovarian responses among the three groups. There was a statistically significant increase in
clinical pregnancy rate per cycle in the endometrioma group (69.7%) versus the ovariolysis group (48.1%) and
tubal factor group (48.0%). However, there was no significant difference in delivery rate per cycle among the
three groups. There was a statistically significant higher miscarriage rate in the endometrioma group (39.1%)
compared with the ovariolysis group (11.5%) and tubal factor group (14.3%). Conclusion: In conclusion, our
study suggests that endometrioma excision surgery does not compromise the overall ovarian reserve or preg-
nancy outcomes after IVF-ET. ( J GYNECOL SURG 31:214)
Introduction
Endometriosis is a benign disease characterized by thepresence of endometrial glands and stroma outside the
uterus. Its overall prevalence among reproductive agewomen is
estimated to be between 3% and 10%, but it affects between
20%and40%of infertilewomen.1 Endometriomas affect 17%–
44% of women with endometriosis.2 The origin of ovarian
endometrioma is unknown; however, it is generally believed
that they result initially from a deposit of endometrium passed
through the fallopian tube, causing adherence of the ovary to the
pelvic peritoneum and progressive invagination of the ovarian
cortex.3–5
Endometriomas are associated with increased oxidative
stress and vascular compromise that can cause damage to
ovarian reserve and function.6 Controversy exists with re-
spect to their management. Surgical resection of en-
dometriomas is widely practiced to overcome infertility, due
to poor response to medical therapy, but this practice is not
yet supported by solid evidence.6 A risk of surgical removal
of ovarian endometrioma is the inadvertent loss of normal
ovarian tissue.7 There are studies that suggest that excision
of endometriomas is associated with a reduction in anti-
mu¨llerian hormone (AMH) levels, suggestive of a decrease
in ovarian reserve, which can have significant implications
on fertility outcomes.8–10
The purpose of this study was to examine the effect of
endometrioma excision on pregnancy outcomes in women
with advanced-stage endometriosis underdoing in vitro fer-
tilization and embryo transfer (IVF-ET).
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This is a historical cohort study using a retrospective chart
review and a database from the years 1991 to 2009 of in-
fertile patients who presented to our unit. The study was
approved by the Institutional Review Board at Hurley
Medical Center, Michigan Flint.
A total of 141 patients were included in our study. The in-
clusion criteria for the study group (group 1) were infertile pa-
tients undergoing IVF-ET with stage III/IV endometriosis and
a history of unilateral or bilateral laparoscopic endometrioma
excision (n=25). The diagnosis of endometrioma was histo-
logically confirmed. The control groups included patients who
had stage III/IV endometriosis but no endometrioma who un-
derwent ovariolysis and (group 2, n=40) and patients with tubal
factors infertility who underwent tubal surgery (group 3, n= 76).
Group 3 consisted of patients with no laparoscopic evidence
of endometriosis who underwent tubal surgery for tubal factor
infertility, failed to conceive, and, subsequently, underwent
IVF-ET.
The operative laparoscopy and IVF-ET were performed by
the same group of infertility specialists (Mostafa I. Abuzeid
and Mohammed Ashraf) under similar operative setting in all
patients. The same surgical techniques were applied in all
patients. When suspicious spots of endometriosis were found
anywhere in the pelvis, in the majority of cases, argon beam
coagulator (Birtcher Medical System, Irvine, CA) was used
to ablate the spots seen. If endometriosis was found on the
pelvic sidewall near the ureter, on the bladder or bowels,
Argon beam coagulator was also used with extra care to avoid
injury to such vital organs. Salpingo-ovariolysis was per-
formed using blunt dissection of the ovary from the pelvic
sidewall, and scissors and/or monopolar diathermy needle tip
(Elmed, Chicago, IL) and Teflon probe (Elmed) to excise the
scar tissue from the tubes and ovaries. If endometrioma more
than 1 cm was found, excision of the cyst wall was done and
reconstruction of the ovarian cortex was performed with one or
two interrupted sutures using 3-0 Vicryl.11 If an endometrioma
of less than 1 cm was found, it was opened, evacuated, and the
lining was ablated with the argon beam coagulator. If fimbrial
phimosis or hydrosalpinges were found, fimbrioplasty or
salpingostomy was performed, respectively, as previously
described by our group.12 Starting in 1999, temporary ovarian
suspension was performed for advanced endometriosis in an
attempt to reduce the risk of recurrence of adhesions be-
tween ovarian fossa and ovaries as previously described by
our group.13
All patients underwent controlled ovarian stimulation (COS)
using mid luteal downregulation protocol with GnRH-agonist
or antagonist protocol and gonadotropin. The starting dose of
gonadotropin was determined based on a woman’s age, body
mass index, antral follicle count at baseline trans-vaginal ultra-
sonography, and day 3 follicle-stimulating hormone (FSH).14
Ovarian response was monitored with frequent serum E2 levels
and trans-vaginal ultrasonography.
The criterion for human chorionic gonadotropin (HCG)
administration was the presence of three or more follicles
that were 17mm in diameter. Cycle cancellation due to poor
ovarian response was undertaken when less than three fol-
licles developed. Oocyte retrieval was carried out under
modified general anesthesia using trans-vaginal ultrasound
(US) guided puncture of follicles at 36 hours after HCG
administration. Standard procedures were carried out for the
gamete–embryo handling, and ET was performed in all
cases using the Wallace catheter. In the period between 1991
and 2001, ET was performed on day 3 after oocyte retrieval.
During the last 7 years, ET was performed on day 5.
Embryos were graded on day 2 based on blastomere
nuclear scoring14 and their morphologic appearance on
day 3 cleavage embryos.15 On day 3, if six to eight em-
bryos were of good quality, the transfer was delayed until
day 5; otherwise, the embryos were transferred on day 3.
Blastocysts were graded according to Gardner’s criteria.16
Ultrasound-guided ET was performed on either day 3 or 5.
Usually, two top-quality embryos/blastocysts were trans-
ferred. Extra good-quality blastocysts were frozen. Luteal
phase support was the same in all groups. Over the years,
different forms of vaginal progesterone were used; however,
the principal remained the same. Starting on the second
day after retrieval: Progesterone vaginal suppositories T.I.D.,
progesterone vaginal cream once a day (Crinone 8% Vaginal
Gel; Watson Pharmaceuticals, Morristown, NJ) or proges-
terone vaginal tablets T.I.D. (Endometrin 100mg Vaginal
Insert; Ferring Pharmaceuticals, Inc., Parsippany, NJ) and
progesterone in oil 100mg I.M. every other day (Proges-
terone in Oil 50mg/mL Vial; Watson Laboratories, Inc.,
Corona, CA) were used. Since the year 2005, Estradiol
B.I.D. (Estrace 2mg; Warner Chilcott LLC, Rockaway, NJ)
were also utilized for luteal phase support. If pregnancy
occurred, the same treatment continued until 6 week of
gestation. At that time, Estrace and Progesterone in Oil were
discontinued, and vaginal progesterone was continued until
12 week of gestation.
Pregnancy was confirmed by measurement of b-HCG at
12 days after blastocyst transfer, or 14 days if ET was done
on day 3. Biochemical pregnancy was defined as a transit
rise in b-HCG, or a positive pregnancy test in the absence of
US scan evidence of pregnancy. Clinical pregnancy was
defined as the presence of a gestational sac on trans-vaginal
US scan at 6 week of gestation. Miscarriage was defined as a
clinical pregnancy that ended in pregnancy loss before 12
weeks of gestation. Delivery was verified by a phone call to
the patient.
Up to two IVF-ET cycles after surgery were analyzed.
The outcomes studied were as follows: pregnancy rate per
cycle, pregnancy rate per patient, delivery rate per cycle,
delivery rate per patient, and miscarriage rate. Statistical
analyses were performed using Student’s t-test, chi-square
test (continuous and dichotomous variables, respectively),












Age 34.3– 4.1 33.1 – 3.9 32.1– 3.2
Duration
of infertility




Septal surgery (%) 28 17.5 17.3

















































and one-way analysis of variance; these were used where
appropriate, considering a p-value < 0.05 as statistically
significant.
Results
Group mean age, mean duration of infertility, type of
infertility, and history of septal surgery were not different
between the three groups, as shown in Table 1. Table 2
illustrates ovarian stimulation characteristics for the patients
undergoing IVF-ET during the first cycle. The mean total
medicine administered in IVF-ET cycle I in group 1, the
patients who underwent endometrioma excision were higher
( p = 0.03). Apart from this, there was no significant differ-
ence among the three groups with respect to the number of
treatment days, E2 levels, progesterone levels, number of
mature follicles on HCG day, number of mature eggs,
number of fertilized eggs, and number of embryos trans-
ferred in IVF-ET cycle I. Patients who did not conceive or
miscarried after the first IVF-ET cycle or whose cycle were
cancelled underwent a second IVF-ET cycle. Table 3 il-
lustrates ovarian stimulation characteristics for the patients
undergoing the second IVF-ET cycle. There was no sig-
nificant difference among the three groups with respect to
the number of treatment days, total dose of gonadotropins
administered, E2 levels, progesterone levels, number of mature
follicles on HCG day, number of mature eggs, number of
fertilized eggs, and number of embryos transferred in IVF-ET
cycle II. Combined pregnancy outcomes following the IVF-ET
cycles I and II are shown in Table 4. The clinical pregnancy
rate per cycle was higher in group 1 compared with groups 2
and 3 (69.7% vs. 48% and 51% respectively; p-value< 0.01).
Miscarriage rate was significantly higher in group 1 compared
with groups 2 and 3 (39.1% vs. 11.5% and 14.3% respectively;
p-value <0.003). There was no significant difference in the
delivery rate per cycle and delivery rate per patient among the
three groups (Table 4).
Discussion
The appropriate management of endometriomas in women
suffering from subfertility is still a topic of debate. Several
surgical techniques have been described. Most involve
opening and draining the cyst followed by either excision
using the stripping technique or ablation of the cyst wall with
electrocautery or CO2 laser.
17 Due to a high recurrence rate,
drainage alone is not recommended.17 A Cochrane review
found that excisional surgery provides better outcomes than
ablative surgery.18 Donnez et al. (2010) described a combined
technique using both excision and ablation to minimize ovary
damage and recurrence rates.19
The main concern with surgery is the associated inadver-
tent removal of ovarian parenchyma that can have a signifi-
cant impact on ovarian reserve. Muzii et al. showed that the
stripping technique removes ovarian tissue in about 54% of
cases.20 A significant reduction in ovarian reserve has also
been demonstrated after endometrioma excision as assessed
by decreased AMH levels and antral follicle counts.8–10 Bu-
sacca et al. reported 2.4% rate of premature ovarian failure
immediately after bilateral endometrioma surgery.21 Such a
report is alarming, since bilateral lesions account for 19%–
28% in patients with ovarian endometriosis.22 Coccia et al.
have also shown that in women previously subjected to bi-
lateral endometrioma removal, the mean age at menopause is
Table 2. Variables in IVF-ET Cycle I
Variables
Endometrioma excision,
group 1 (n = 25)
Ovariolysis
group, 2 (n = 40)
Tubal group,
group 3 (n = 76)
Days till HCG 10.4 – 1.6 11.0 – 1.4 11.0 – 1.9
Total dose of gonadotropin administered (I.U.)* 3825.0 – 1473.5 3101.6 – 1185.1 3071.8 – 1269.6
No. of mature follicles 8.5 – 4.4 10.3 – 5.6 9.8 – 4.9
Estrogen level (pg/mL) 2062.4 – 813.3 2230.0 – 1068.5 2072.9 – 1102.7
Progesterone level (ng/mL) 0.9 – 0.4 1.1 – 0.6 1.0 – 0.8
No. of mature eggs 9.2 – 4.4 10.0 – 5.5 10.7 – 5.7
No. of fertilized eggs 7.5 – 4.4 7.6 – 4.7 8.6 – 5.4
No. of embryos transferred 3.2 – 1.2 3.1 – 1.3 3.0 – 1.3
*p = 0.03.
HCG, human chorionic gonadotropin; IVF-ET, in vitro fertilization and embryo transfer.
Table 3. Variables in IVF-ET Cycle II
Variables
Endometrioma excision,
group 1 (n= 8)
Ovariolysis,
group 2 (n = 14)
Tubal group,
group 3 (n = 26)
Days till HCG 10.5 – 1.4 10.5 – 1.5 10.9 – 1.85
Total medication administered 4219– 548 3081.7 – 1299 3305– 1431
No. of mature follicles 7 – 2.2 10.7 – 6.5 9.15 – 3.8
Estrogen level 1834– 103.1 2282.5 – 1173 2175.4 – 968
Progesterone level 1.0 – 0.4 1.0 – 0.8 1.2 – 0.6
No. of mature eggs 8.6 – 3.7 10.5 – 6.9 10 – 4.3
No. of fertilized eggs 6.0 – 1.6 8.5 – 6.3 8.0 – 4.1
No. of embryos transferred 3.5 – 1.1 3.7 – 1.7 3.3 – 1.7

















































significantly lower.23 Factors shown to influence ovarian re-
serve after surgery are the expertise of the surgeon, the size of
the cyst, and the composition of the cyst wall.10,24 Yu et al.
showed a significantly diminished antral follicle count in the
hands of an inexperienced surgeon for both unilateral and
bilateral cystectomies.10 Romualdi et al. showed that the
smaller cysts and fibroblastic capsular types were more as-
sociated with the follicles being removed during surgery,
likely due to less demarcated cleavage plane.24 In such pa-
tients, de-roofing and ablation is the preferred procedure to
minimize follicular loss.
The effect of ovarian surgery on ovarian response to
fertility medications is subject to a matter of debate. Criteria
for poor ovarian response include small numbers of devel-
oped follicles or retrieved oocytes, and low estradiol (E2)
levels.25 Our study showed no difference in the overall
ovarian responses among the three populations studied. In
two of such populations studied (group 2 and group 3),
excision of endometrioma was not performed. Therefore,
our data suggest that excision of endometrioma does not
affect ovarian response to fertility medications. Similarly,
Canis et al. in a retrospective study showed that in the hands
of an experienced surgeon there was no significant reduction
in the number of oocytes retrieved.25 In addition, in a retro-
spective study of women with severe endometriosis who
underwent laparoscopic vaporization of the cyst wall, Donnez
et al. showed that in women with unilateral endometriomas
undergoing excision there was a similar ovarian response in
cystectomized ovaries when compared with the contralateral
nonoperated ovary.26 In a Cochrane review in 2008, Hart
et al. showed an increased ovarian response with excisional
procedures than with ablative procedures for endometrioma
removal in women undergoing IVF.18 On the other hand,
several retrospective studies have reported reduced responses
to gonadotrophins after endometrioma excision.27–31 Such
discrepancy in the literature can be related to the experience
of the surgeon and other surgical factors such as the nature of
cyst, the baseline ovarian reserve in some patients, and sur-
gical technique as mentioned earlier.
Our study showed that the mean total dose of gonadotropin
administered in IVF-ET cycle I was higher ( p= 0.03) in pa-
tients who underwent endometrioma excision. This could be
related to an element of decrease ovarian reserve secondary to
surgery and is consistent with existing studies. However, such
differences were not seen in the second cycle, probably due to
the smaller sample size (group 1: n= 8, group 2: n= 14 and
group 3: n= 26). Similarly, other investigators have reported
higher gonadotrophin dose after endometrioma excision sur-
gery in women undergoing IVF.32–34
Our study showed a statistically significant increase in
pregnancy rate per cycle in the endometrioma group (69.7%)
versus in the ovariolysis group (48.1%) and tubal factor group
(48.0%). The delivery rates per cycle and per patient were not
significantly different among the three groups. This could be
explained by the statistically significant increase in miscarriage
rate in the endometrioma group (39.1%) versus the ovariolysis
group (11.5%) and tubal factors group (14.3%). Similar to our
overall results, In a retrospective study of women with severe
endometriosis who underwent laparoscopic vaporization of the
cyst wall, Donnez et al. showed similar IVF outcomes when
compared with women having tubal infertility.26 However, the
effect of ovarian surgery on pregnancy rates in women un-
dergoing IVF-ET is still a matter of debate. In a randomized
controlled trial, Demirol et al.showed that ovarian surgery in
women undergoing IVF treatment did not affect the fertiliza-
tion, implantation, and pregnancy rates.33 Similarly, Garcia-
Velasco et al. showed that previous endometrioma excision
surgery in women undergoing IVF did not improve the number
of oocytes retrieved, number of embryos obtained/transferred,
and the pregnancy rates.34,35 Yu et al. showed better live
birth rates when experienced laparoscopic surgeons treated
endometriomas in women undergoing IVF.10 In a Cochrane
review, Hart et al.showed that removal of endometriomas
were associated with a significant increase of spontaneous
pregnancy in subfertile women.18
The association between endometriosis and an increased
risk of spontaneous miscarriage is also a topic of debate.
There have been retrospective studies in the past that have
shown an increased risk of pregnancy loss with endometri-
osis.36–38 These studies lacked control groups. More recent
studies have refuted this and shown no causal relation-
ship.39,40 Our study showed an increased miscarriage rate in
the endometrioma excision group in comparison to the
ovariolysis group, although patients in both groups had stage
III/VI endometriosis. In addition, our data suggest higher
miscarriage rate in the endometrioma excision group com-
pared with the tubal factor group. More research in needed
to evaluate the possible association between miscarriage
and some patients with endometriosis, especially after IVF
treatment.
Table 4. Combined Pregnancy Outcomes After IVF-ET Cycles I and II
Endometrioma excision,
group 1 (N = 25)
Ovariolysis,
group 2 (N= 40)
Tubal, group 3
(N = 76)
No. of IVF-ET cycles 33 54 102
No. of clinical pregnancies 23 26 49
Clinical pregnancy rate per cycle (%)* 69.7 48.1 48.0
No. of patients delivered 14 23 42
Delivery rate per cycle (%) 42.2 42.6 41.2
Delivery rate per patient (%) 56.0 57.5 55.3
No. of miscarriages (%)** 9 (39.1) 3 (11.5) 7 (14.3)
*p-Value < 0.01.
**p-Value < 0.001.
IVF-ET Cycle, in vitro fertilization embryo transfer.

















































Our study has some limitations as a result of its retro-
spective nature with the inherent biases that are associated
with such design and its sample size, which may limit its
generalizability. One area of strength is there were no sig-
nificant differences in age, duration of infertility, or the type
of infertility between the three populations studied. Another
area of strength in our study is the fact that all surgeries were
performed using the same technique. In addition, during IVF-
ET, all COS and ETs were performed by only two physicians
(Mostafa I. Abuzeid and Mohammed Ashraf), which limit
confounding factors that may affect implantation rates and,
in turn, pregnancy outcomes. Our study compared the study
group (patients who had endometrioma excision) with an-
other group of patients with the same stage of endometriosis
except that they had no endometrioma. This may have con-
trolled for some confounding factors related to endometriosis,
whereas most existing studies have only tubal factor infer-
tility as the control group.
Conclusion
Our study suggests that excision of endometrioma in pa-
tients with advanced endometriosis before IVF-ET treat-
ment does not compromise the overall ovarian reserve or
pregnancy outcomes. Large, prospective, and randomized
controlled trials are still required to shed more light on this
matter.
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